Comparison of Intraoperative Hemodynamic Parameters and Arterial-blood Gas Changes at Two Different Pneumoperitoneal Pressure Values

May 4, 2022 updated by: Eva Intagliata

Laparoscopic Surgery: Comparison of Intraoperative Hemodynamic Parameters and Arterial-blood Gas Changes at Two Different Pneumoperitoneal Pressure Values

Clinic and metabolic consequences of pneumoperitoneum, achieved by insufflation of gas carbon dioxide, are still debated. Cardiovascular system suffering due to the compression of intra-abdominal venous structures can cause life-threatening complications. Increased partial pressure of carbon dioxide induces metabolic acidosis with further vascular suffering. Pneumoperitoneum reduces the pulmonary exchange volumes and bring renal suffering.

Methods. The aim of this study is to evaluate the alterations in hemodynamic and hemogasanalysis parameters during the laparoscopic surgery at different pressure settings of pneumoperitoneum in order to assess the best pressure value.

We evaluated and compared intraoperative hemodynamic and hemogasanalytic alterations in two groups of patients respectively subdue to laparoscopic cholecystectomy at a pneumoperitoneum pressure of 12 mmHg (group A) and at a pressure of 8 mmHg (group B).

Study Overview

Status

Completed

Conditions

Detailed Description

We evaluated intraoperative hemodynamic and hemogasanalytic alterations in two groups of randomized patients respectively operated at a pneumoperitoneum pressure of 12 mmHg (group A) and at a pressure of 8 mmHg (group B) to highlight any significant alterations.

The clinical sample used in the study is composed by patients aged between 15 and 85 years affected by cholelithiasis and treated with laparoscopic cholecystectomy in the period between July 2019 and February 2020.

20 patients, 9 men and 11 women, were enrolled. Group A included 10 patients, 5 men and 5 women, with an average age of 47.9 years. Group B included 10 patients, 4 men and 6 women, with an average age of 50.7 years.

The parameters evaluated were: heart rate (HR), average arterial blood pressure (BP), respiratory frequency (RF), oxygen saturation (SaO2), hemogasanalysis (PaO2, PaCO2, pH and HCO3-).

The measurements were made at four stages: before the induction of anesthesia, after the anesthesia induction but before incision, 30 minutes after the pneumoperitoneum induction, 5 minutes after the pneumoperitoneum releasing.

The hemodynamic parameters (HR, RF, BP, SaO2) were extrapolated from the multiparameter monitor for each evaluation. The hemogasanalytic values (PaO2, PaCO2, pH and HCO3) were evaluated by the radial arterial sampling. The average and standard deviation were calculated for the quantitative data normally distributed. For the comparison of the quantitative data, the t-student test was used. A value of p ≤ 0,05 was considered statistically significant.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Catania, Italy, 95123
        • Eva Intagliata

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 85 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients aged between 15 and 85 years affected by symptomatic cholelithiasis and treated with laparoscopic cholecystectomy

Description

Inclusion Criteria: cholelithiasis -

Exclusion Criteria: immunodeficiency disorders, chronic use of corticosteroids, non-compensated diabetes mellitus, major morbidity with a life expectancy of less than 30 days, significant anemia (hemoglobin < 7 gr/Dl or hematocrit < 21%), coagulopathies, ascites, chronic pain treatment, severe comorbidities

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group A
pneumoperitoneum pressure of 12 mmHg
removal of the gallbladder by laparoscopy at pneumoperitoneum pressure setting of 12 or 8 mmHg
Group B
pneumoperitoneum pressure of 8 mmHg
removal of the gallbladder by laparoscopy at pneumoperitoneum pressure setting of 12 or 8 mmHg

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hearth rate
Time Frame: before the induction of anesthesia
hearth rate variations
before the induction of anesthesia
hearth rate
Time Frame: after the anesthesia induction but before incision
hearth rate variations
after the anesthesia induction but before incision
hearth rate
Time Frame: 30 minutes after the pneumoperitoneum induction
hearth rate variations
30 minutes after the pneumoperitoneum induction
hearth rate
Time Frame: 5 minutes after the pneumoperitoneum releasing
hearth rate variations
5 minutes after the pneumoperitoneum releasing
arterial blood pressure
Time Frame: before the induction of anesthesia
average arterial blood pressure variations
before the induction of anesthesia
arterial blood pressure
Time Frame: after the anesthesia induction but before incision
average arterial blood pressure variations
after the anesthesia induction but before incision
arterial blood pressure
Time Frame: 30 minutes after the pneumoperitoneum induction
average arterial blood pressure variations
30 minutes after the pneumoperitoneum induction
arterial blood pressure
Time Frame: 5 minutes after the pneumoperitoneum releasing
average arterial blood pressure variations
5 minutes after the pneumoperitoneum releasing
respiratory frequency
Time Frame: before the induction of anesthesia
respiratory frequency variations
before the induction of anesthesia
respiratory frequency
Time Frame: after the anesthesia induction but before incision
respiratory frequency variations
after the anesthesia induction but before incision
respiratory frequency
Time Frame: 30 minutes after the pneumoperitoneum induction
respiratory frequency variations
30 minutes after the pneumoperitoneum induction
respiratory frequency
Time Frame: 5 minutes after the pneumoperitoneum releasing
respiratory frequency variations
5 minutes after the pneumoperitoneum releasing
oxygen saturation
Time Frame: before the induction of anesthesia
oxygen saturation variations
before the induction of anesthesia
oxygen saturation
Time Frame: after the anesthesia induction but before incision
oxygen saturation variations
after the anesthesia induction but before incision
oxygen saturation
Time Frame: 30 minutes after the pneumoperitoneum induction
oxygen saturation variations
30 minutes after the pneumoperitoneum induction
oxygen saturation
Time Frame: 5 minutes after the pneumoperitoneum releasing
oxygen saturation variations
5 minutes after the pneumoperitoneum releasing
blood gas analysis
Time Frame: before the induction of anesthesia
blood gas analysis variations
before the induction of anesthesia
blood gas analysis
Time Frame: after the anesthesia induction but before incision
blood gas analysis variations
after the anesthesia induction but before incision
blood gas analysis
Time Frame: 30 minutes after the pneumoperitoneum induction
blood gas analysis variations
30 minutes after the pneumoperitoneum induction
blood gas analysis
Time Frame: 5 minutes after the pneumoperitoneum releasing
blood gas analysis variations
5 minutes after the pneumoperitoneum releasing

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2019

Primary Completion (ACTUAL)

February 1, 2020

Study Completion (ACTUAL)

February 28, 2020

Study Registration Dates

First Submitted

April 14, 2022

First Submitted That Met QC Criteria

May 4, 2022

First Posted (ACTUAL)

May 10, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 10, 2022

Last Update Submitted That Met QC Criteria

May 4, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UCatania000

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumoperitoneum

Clinical Trials on laparoscopic cholecystectomy

3
Subscribe